Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 1 | 512 aa | 505 aa | 26.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 1 | 0.5 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.002 | 1 | 0.5 |
Onchocerca volvulus | Dopamine\/Ecdysteroid receptor homolog | 0.0005 | 0 | 0.5 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.001 | 0.3451 | 1 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 1 | 0.5 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.001 | 0.3192 | 0.3192 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 1 | 1 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.001 | 0.3451 | 0.3451 |
Plasmodium falciparum | ATP-dependent DNA helicase Q1 | 0.002 | 1 | 0.5 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Echinococcus multilocularis | ATP dependent DNA helicase Q5 | 0.002 | 1 | 1 |
Entamoeba histolytica | recQ family helicase, putative | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Echinococcus multilocularis | ATP dependent DNA helicase Q1 | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Trichomonas vaginalis | DNA helicase recq, putative | 0.002 | 1 | 0.5 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.3451 | 0.3451 |
Echinococcus granulosus | bloom syndrome protein | 0.002 | 1 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Entamoeba histolytica | recQ family DNA helicase | 0.001 | 0.3451 | 0.0381 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.3451 | 0.0381 |
Loa Loa (eye worm) | RecQ helicase | 0.002 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.3451 | 0.3451 |
Treponema pallidum | ATP-dependent DNA helicase | 0.001 | 0.3451 | 0.5 |
Echinococcus granulosus | ATP dependent DNA helicase Q1 | 0.002 | 1 | 1 |
Schistosoma mansoni | DNA helicase recq5 | 0.002 | 1 | 1 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.002 | 1 | 0.5 |
Echinococcus multilocularis | bloom syndrome protein | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Echinococcus granulosus | ATP dependent DNA helicase Q5 | 0.002 | 1 | 1 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.002 | 1 | 0.5 |
Onchocerca volvulus | Neuropeptide F receptor homolog | 0.0005 | 0 | 0.5 |
Schistosoma mansoni | DNA helicase recq1 | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Brugia malayi | Bloom's syndrome protein homolog | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 1 | 1 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.002 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.